FXH Among Health Care ETFs
End-of-day Nov 18, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.0% | −4.3% | −1.2% | −0.1% | +17.8% | +20.7% | +47.7% | +13.4% | +139.3% | +587.1% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$27 of every $1,000 in FXH is Centene
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | CNCCentene | Healthcare | 2.69% | $269.43 | 430K | $31.2M |
| 2 | ZBHZimmer Biomet | Healthcare | 2.65% | $265.13 | 301K | $30.7M |
| 3 | UHSUniversal Health Services, () | Healthcare | 2.54% | $254.15 | 153K | $29.4M |
| 4 | CIThe Cigna Group | Healthcare | 2.50% | $249.56 | 98K | $28.9M |
| 5 | MEDPMedpace | Healthcare | 2.41% | $241.38 | 43K | $28.0M |
| 6 | REGNRegeneron Pharmaceuticals | Healthcare | 2.33% | $233.10 | 28K | $27.0M |
| 7 | GEHCGE HealthCare Technologies | Healthcare | 2.31% | $231.05 | 327K | $26.8M |
| 8 | LLYEli Lilly and Company | Healthcare | 2.26% | $225.80 | 18K | $26.2M |
| 9 | SOLVSolventum | Healthcare | 2.25% | $225.22 | 303K | $26.1M |
| 10 | ZTSZoetis | Healthcare | 2.21% | $220.63 | 306K | $25.6M |
| 11 | DXCMDexCom | Healthcare | 2.19% | $219.33 | 310K | $25.4M |
| 12 | EXELExelixis | Healthcare | 2.16% | $216.44 | 366K | $25.1M |
| 13 | GMEDGlobus Medical, () | Healthcare | 2.16% | $215.57 | 357K | $25.0M |
| 14 | MDTMedtronic | Healthcare | 2.10% | $209.61 | 237K | $24.3M |
| 15 | THCTenet Healthcare | Healthcare | 2.04% | $203.70 | 84K | $23.6M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | CNC | Centene | 2.69% |
| 2 | ZBH | Zimmer Biomet | 2.65% |
| 3 | UHS | Universal Health Services, () | 2.54% |
| 4 | CI | The Cigna Group | 2.50% |
| 5 | MEDP | Medpace | 2.41% |
| 6 | REGN | Regeneron Pharmaceuticals | 2.33% |
| 7 | GEHC | GE HealthCare Technologies | 2.31% |
| 8 | LLY | Eli Lilly and Company | 2.26% |
| 9 | SOLV | Solventum | 2.25% |
| 10 | ZTS | Zoetis | 2.21% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 30, 2026 | $0.29 |
| Jun 25, 2026 | Jun 30, 2026 | $0.12 |
| Mar 26, 2026 | Mar 31, 2026 | $0.19 |
| Dec 12, 2025 | Dec 31, 2025 | $0.14 |
| Sep 25, 2025 | Sep 30, 2025 | $0.58 |
| Jun 26, 2025 | Jun 30, 2025 | $0.0616 |
| Mar 27, 2025 | Mar 31, 2025 | $0.0669 |
| Dec 13, 2024 | Dec 31, 2024 | $0.0899 |
| Sep 26, 2024 | Sep 30, 2024 | $0.13 |
| Jun 27, 2024 | Jun 28, 2024 | $0.11 |
| Mar 21, 2024 | Mar 28, 2024 | $0.11 |
| Dec 22, 2023 | Dec 29, 2023 | $0.13 |